By |

Profile

Insmed Inc is a global biotechnology company that is focused on developing novel therapies for rare diseases. The company works to develop and commercialize therapies that focus primarily on lung diseases. Insmed is focused broadly on rare disease therapeutics and prioritizing its current therapeutic focus in the fields of pulmonology and infectious disease. The company's strategy includes licensing its patents and pending patent applications. The company's primary businesses are within the U.S., Europe, and Canada, while also maintaining operations in other international markets as well.

Contact Information

Website: www.insmed.com
Email: blaine.davis@insmed.com
Main Phone: +1 908 977-9900
Address: 10 Finderne Avenue
Address 2: Building 10
State: NJ
City / Town: Bridgewater
Country: USA
Postal Code: 08807

Issuer Information

Exchange: NGS
CEO: William Lewis
Employees: 373
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Insmed Inc is a global biotechnology company that is focused on developing novel therapies for rare diseases. The company works to develop and commercialize therapies that focus primarily on lung diseases. Insmed is focused broadly on rare disease therapeutics and prioritizing its current therapeutic focus in the fields of pulmonology and infectious disease. The company's strategy includes licensing its patents and pending patent applications. The company's primary businesses are within the U.S., Europe, and Canada, while also maintaining operations in other international markets as well.

Contact Information

Website: www.insmed.com
Email: blaine.davis@insmed.com
Main Phone: +1 908 977-9900
Address: 10 Finderne Avenue
Address 2: Building 10
State: NJ
City / Town: Bridgewater
Country: USA
Postal Code: 08807

Issuer Information

Exchange: NGS
CEO: William Lewis
Employees: 373
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 28.21 $ -0.96 (-3.29%)
Last Price 28.21 Change $ -0.96 Change % -3.29 Tick N/A
Bid 27.73 Bid Size 100.00 Ask 28.98 Ask Size 300.00
Open 28.86 High 29.00 Low 28.20 Prev Close 29.17
Last Trade Volume 662,575 52 Wk Hi 31.58 52 Wk Low 11.31
Market Cap 2.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 77,538,562.00 EPS (TTM) -4.22 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 11 30
Number of Buys 9 19
Number of Sells 2 11
Net Activity 42462 90128
Last 10 Buys Shares
Christine A. Pellizzari 1,000
Christine A. Pellizzari 1,000
William Lewis 1,000
Melvin Sharoky 1,000
William Lewis 1,000
William Lewis 1,000
William Lewis 1,000
William Lewis 1,000
William Lewis 1,000
William Lewis 1,000
Last 10 Sell Shares
S. Nicole Schaeffer 1,000
S. Nicole Schaeffer 1,000
Donald J. Hayden 1,000
Donald J. Hayden 1,000
Melvin Sharoky 1,000
Melvin Sharoky 1,000
Donald J. Hayden 1,000
Donald J. Hayden 1,000
Melvin Sharoky 1,000
Melvin Sharoky 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 56 56 56 56
Low Target Price Estimate 35 35 35 35
Mean Target Price Estimate 41.67 41.67 41.71 41.67
Standard Deviation 7.53 7.53 6.87 7.53
Date of Most Recent Estimate 05/07/18 05/07/18 05/07/18 05/07/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 6 6 6
Moderate Buy 1 1 1 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.08 1.07 1.07 1